Skip to main content

Table 1 Associtions between miR-639 and clinical parameters (n = 158)

From: miR-639 promotes the proliferation and invasion of breast cancer cell in vitro

Characteristic No. of patients miR-639 ΔCt a P
  No. % Mean ± SD  
Age, years     
 ≥60 69 43.7 1.71 ± 0.17 0.664
 <60 89 56.3 1.64 ± 0.21  
Pathologe grade     
 I 56 35.4 1.69 ± 0.21  
 II 49 31.0 1.86 ± 0.14 0.089
 III 53 33.5 1.98 ± 0.15  
T stage     
T1 57 36.1 1.54 ± 0.27 0.471
T2 50 31.6 1.65 ± 0.24  
T3 51 32.3 1.33 ± 0.17  
M stage     
 M0 76 48.1 1.19 ± 0.14 0.024
 M1 82 51.9 2.11 ± 0.31  
Histologic signs of severity (vascular emboli, perineural invasion, diffuse infiltration)     
 None 77 48.7 1.57 ± 0.23 0.038
 Presence 74 46.8 1.73 ± 0.17  
 Missing 7 4.4   
Smoking history     
 Nonsmoker 111 70.3 1.37 ± 0.23 0.625
 Smoker 39 24.7 1.47 ± 0.21  
 Missing 8 5.1   
Alcohol history     
 Nondrinker 107 67.7 1.35 ± 0.29 0.225
 Drinker 42 26.6 1.27 ± 0.36  
 Missing 9 5.7   
  1. Abbreviations: SD standard deviation, T tumor stage, N lymphnode stage.
  2. aΔCt indicates the difference in the cycle number at which a sample’s fluorescent signal passes a given threshold above baseline (Ct) derived from a specific gene compared with that of U6 in tumor tissues.